Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.42
+0.11 (2.07%)
At close: Dec 5, 2025, 4:00 PM EST
5.38
-0.04 (-0.74%)
After-hours: Dec 5, 2025, 4:04 PM EST
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $10.40 million as of December 5, 2025. Its market cap has decreased by -51.37% in one year.
Market Cap
10.40M
Enterprise Value
2.08M
1-Year Change
-51.37%
Ranking
Category
Stock Price
$5.42
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $10.40M, a decrease of -98.49%. That is a compound annual growth rate of -58.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 10.19M | -50.23% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |